שווי פירמה כולל: Sionna Therapeutics Inc (SION)
Sionna Therapeutics Inc (SION) specializes in developing advanced treatments for cystic fibrosis. The company utilizes nitrogen-based cryogenic systems for the transport of biomaterials. The price indicator on the GURU.Markets chart is -22.11, confirming available resources and cost control. The business model relies on the clinical trial progression of unique molecules, which determines the overall success of this biotech's development strategy.
Sionna Therapeutics Inc (SION) - פילוחי מדדים ודוחות פיננסיים
The indicator's formula is highly sensitive to the balance between borrowed funds and liquidity. This metric determines the total cost of business acquisition by summing market capitalization and debt, minus cash reserves. For Sionna Therapeutics Inc (SION), this calculation is critical due to geopolitical risks affecting supply chain costs and patent protection. By analyzing the estimated enterprise value on GURU.Markets, an investor assesses the asset's real price. The dynamics of this line help avoid overpaying during a purchase.